Bryostatin 1 Induces Prolonged Activation of Extracellular Regulated Protein Kinases in and Apoptosis of LNCaP Human Prostate Cancer Cells Overexpressing Protein Kinase Cα

  1. Jürgen E. Gschwend1,
  2. William R. Fair and
  3. C. Thomas Powell
  1. Urologic Oncology Research Laboratory and George M. O'Brien Urology Research Center for Prostate Cancer, Memorial Sloan-Kettering Cancer Center, New York, New York

    Abstract

    Previously, we reported that 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced apoptosis of LNCaP human prostate cancer cells was accompanied by prolonged translocation of protein kinase C (PKC)α to non-nuclear membranes and that TPA-resistant LNCaP cells had down-regulated PKCα. Here we show that 10 nM bryostatin 1 induced transient membrane translocation and down-regulation of PKCα, prolonged translocation of PKCδ and ε to non-nuclear membranes, and did not induce cell death but blocked TPA-induced apoptosis. To test the hypothesis that inhibition of TPA-induced apoptosis by bryostatin 1 was due to down-regulation of PKCα, we inducibly overexpressed PKCα in LNCaP cells. Overexpression of PKCα alone did not induce apoptosis, even in clones that contained much more membrane-bound, active PKCα than was observed in TPA-treated untransfected LNCaP cells. However, the addition of 10 nM bryostatin 1 to PKCα-overexpressing LNCaP cells did not yield down-regulation of PKCα and induced extensive apoptosis. Immunoblot analysis revealed that TPA induced prolonged hyperphosphorylation of Raf-1 and activation of extracellular-regulated/mitogen-activated protein kinases 1 and 2 in untransfected LNCaP cells, as did bryostatin 1 in PKCα-overexpressing cells. On the other hand, bryostatin 1 induced only transient hyperphosphorylation of Raf-1 and activation of extracellular-regulated/mitogen-activated protein kinases 1 and 2 in untransfected LNCaP cells. These results confirm a role of prolonged membrane-associated PKCα in PKC activator-mediated LNCaP apoptosis and suggest involvement of the mitogen-activated protein kinase pathway.

    Footnotes

    • Send reprint requests to: C. Thomas Powell, Ph.D., Department of Cancer Biology, The Cleveland Clinic Foundation, 9500 Euclid Ave.-ND50, Cleveland, OH 44195.

    • 1 Current address: Department of Urology, University of Ulm, 89075 Ulm, Germany.

    • This work was supported in part by National Institutes of Health Grant DK/CA47650. J.E.G. was supported by Deutsche Forschungsgemeinschaft (Bonn, Germany).

    • Abbreviations:
      TPA
      12-O-tetradecanoylphorbol-13-acetate
      ERK
      extracellular-regulated/mitogen-activated protein kinase
      FBS
      fetal bovine serum
      PKC
      protein kinase C
      tet
      tetracycline
      tTA
      tetracycline-repressible transactivator protein
      XTT
      2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt
      • Received September 3, 1999.
      • Accepted February 23, 2000.
    « Previous | Next Article »Table of Contents